Children represent approximately 24% of the U.S. population, yet they remain excluded from current COVID-19 vaccination efforts because clinical trials have not yet confirmed safety and efficacy for younger age groups. While children generally experience milder symptoms, they remain capable of transmitting the virus, meaning herd immunity is unattainable without their participation. Science reporter Apoorva Mandavilli notes that while trials for adolescents are underway, widespread pediatric vaccination is unlikely before the end of the year. This creates a significant public health gap, necessitating the continued use of masks and social distancing even as adult vaccination rates rise. Furthermore, the potential emergence of viral variants threatens to trigger a fourth wave of infections, underscoring the urgency of maintaining rigorous safety precautions until a broader portion of the population, including children, achieves immunity.
Sign in to continue reading, translating and more.
Continue